In addition to their prognostic role, PRL appear specific to MS, as they have been rarely detected in patients with other neurological conditions (52% of MS vs 7% of non-MS in a multicenter study of 438 individuals) (Maggi et al., 2020). Here, PRL is linked to myeloid sarcoma.